CRISPR/Cas-based technologies have revolutionized genetic approaches to addressing a wide range of neurobiological questions. The ability of CRISPR/Cas to introduce mutations into target genes allows us to perform in vivo loss-of-function experiments without generating genetically engineered mice. However, the lack of a reliable method to determine genotypes of individual CRISPR/Cas-transfected cells has made it impossible to unambiguously identify the genetic cause of their phenotypes in vivo. Here, we report a strategy for single-cell genotyping in CRISPR/Cas-transfected neurons that were phenotypically characterized in vivo. We show that re-sectioning of cortical slices and subsequent laser microdissection allow us to isolate individual CRISPR/Cas-transfected neurons. Sequencing of PCR products containing a CRISPR/Cas-targeted genomic region in single reference neurons provided genotypes that completely correspond with those deduced from their target protein expression and phenotypes. Thus, our study establishes a powerful strategy to determine the causality between genotypes and phenotypes in CRISPR/Cas-transfected neurons.
You may also like
New study reveals ‘moonlighting’ function of part...
May 26, 2023Max Planck Institute for Brain Research
Competition between brain hemispheres during sleep
March 27, 2023Max Planck Institute for Brain Research
New Research Shows How Cultural Transmission Shapes...
March 27, 2023Max Planck Institute for Empirical Aesthetics
Modeling the turtle brain provides insights: Routing...
February 15, 2023Max Planck Institute for Brain Research
Amygdala Intercalated Cells: Gatekeepers and Conveyors...
January 19, 2023Max Planck Florida Institute for Neuroscience
Aversive bimodal associations differently impact...
January 19, 2023Max Planck Institute for Chemical Ecology